IL118364A0 - A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus - Google Patents
A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virusInfo
- Publication number
- IL118364A0 IL118364A0 IL11836496A IL11836496A IL118364A0 IL 118364 A0 IL118364 A0 IL 118364A0 IL 11836496 A IL11836496 A IL 11836496A IL 11836496 A IL11836496 A IL 11836496A IL 118364 A0 IL118364 A0 IL 118364A0
- Authority
- IL
- Israel
- Prior art keywords
- hepatitis
- virus
- assays
- preparation
- detection
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 2
- 238000003556 assay Methods 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44727695A | 1995-05-22 | 1995-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL118364A0 true IL118364A0 (en) | 1996-09-12 |
Family
ID=23775707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11836496A IL118364A0 (en) | 1995-05-22 | 1996-05-22 | A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5924396A (en) |
IL (1) | IL118364A0 (en) |
WO (1) | WO1996037606A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078500B1 (en) | 1998-01-30 | 2006-07-18 | The General Hospital Corporation | Genetic immunization with nonstructural proteins of hepatitis C virus |
KR20060057653A (en) * | 1998-01-30 | 2006-05-26 | 더 제너럴 하스피탈 코포레이션 | Genetic immunization with nonstructural proteins of hepatitis c virus |
GB0226722D0 (en) * | 2002-11-15 | 2002-12-24 | Glaxo Group Ltd | Vaccine |
BR102018071672A2 (en) * | 2018-10-22 | 2021-11-16 | Fundação Oswaldo Cruz | POLYPEPTIDE, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOST CELL, KIT FOR IMMUNOLOGICAL SCREENING OF HCV AND/OR DIAGNOSIS OF HEPATITIS C, COMPOSITION, USE OF AT LEAST ONE POLYPEPTIDE, AND, METHODS FOR PRODUCING A HCV, PARAPEPTIDE FOR THE DIAGNOSIS OF HEPATITIS C |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940000755B1 (en) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Synthetic peptides specific for the detection of antibodies to hcv |
UA41266C2 (en) * | 1990-04-04 | 2001-09-17 | Чірон Корпорейшн | COMBINATION OF HEPATITIS C VIRUS (HCV) EPITOPE SEQUENCES, METHOD OF DETECTION OF ANTIBODIES TO HEPATITIS VIRUS (HCV), KIT FOR ANALYTES ANALYTES ANALYSIS ANALYSIS |
CA2045326A1 (en) * | 1990-06-25 | 1991-12-26 | Hiroto Okayama | Non-a, non-b, hepatitis virus particles |
GB9203803D0 (en) * | 1992-02-21 | 1992-04-08 | Wellcome Found | A recombinant polypeptide |
KR100312535B1 (en) * | 1993-04-30 | 2002-06-20 | 성재갑 | Diagnostic kit of antibody to hepatitis c virus(hcv) using mixed antigen |
-
1996
- 1996-05-22 WO PCT/US1996/007378 patent/WO1996037606A1/en active Application Filing
- 1996-05-22 AU AU59243/96A patent/AU5924396A/en not_active Abandoned
- 1996-05-22 IL IL11836496A patent/IL118364A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU5924396A (en) | 1996-12-11 |
WO1996037606A1 (en) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1447492A (en) | Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv) | |
PL324906A1 (en) | Vaccines against viral hepatitis of c type | |
PL321966A1 (en) | Vaccine against viral hepatitis of b type | |
AU5285899A (en) | Anti hepatitis c virus antibody and uses thereof | |
AU3241095A (en) | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same | |
PL335721A1 (en) | Novel methods of screening serving the purpose of identifying the factors of selective hepatitis c virus replication inhibition | |
AU1566595A (en) | Method and reagent for inhibiting hepatitis c virus replication | |
AU2064297A (en) | Hepatitis c virus ribozymes | |
IL118471A0 (en) | A positive-stranded RNA virus-derived composition methods for making compositions utilizing the same assays for the detection of and vaccines against said viruses | |
AU1905399A (en) | Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds | |
AU3238995A (en) | Hepatitis a virus receptor and methods of use | |
AU7224591A (en) | A rapid and sensitive test for detecting hepatitis a virus | |
EP0747482A3 (en) | Hepatitis GB virus recombinant proteins and uses thereof | |
AU2683792A (en) | Peptide based hepatitis c virus immunoassays | |
EP0711310A4 (en) | Human antibodies against varicella-zoster virus | |
AU3073389A (en) | Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver | |
AU2370592A (en) | Epitopes of the env protein of the hepatitis c virus | |
IL118364A0 (en) | A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus | |
AU4554899A (en) | Novel hepatitis c virus peptides and uses thereof | |
HU9303066D0 (en) | Particle forming multiply hepatitis b virus surface proteins | |
ZA964094B (en) | Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv) | |
ZA964446B (en) | Oligonucleotides specific for hepatitis c virus | |
AU3966995A (en) | Peptides for detection of hepatitis c antibodies | |
AU688259B2 (en) | Hepatitis C virus peptides | |
GR970300022T1 (en) | Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus |